Drug Shortage Report for APO-TRAVOPROST-TIMOP PQ

Last updated on 2023-07-13 History
Report ID 190871
Drug Identification Number 02415305
Brand name APO-TRAVOPROST-TIMOP PQ
Common or Proper name TRAVOPROST / TIMOLOL
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) TIMOLOL TRAVOPROST
Strength(s) 0.5% 0.004%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5 ML
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-04-24
Estimated end date 2023-07-21
Actual end date 2023-07-12
Shortage status Resolved
Updated date 2023-07-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2023-07-13 French Compare
v7 2023-07-13 English Compare
v6 2023-06-29 French Compare
v5 2023-06-29 English Compare
v4 2023-06-09 French Compare
v3 2023-06-09 English Compare
v2 2023-04-27 French Compare
v1 2023-04-27 English Compare

Showing 1 to 8 of 8